BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 6415087)

  • 1. Defective regulation of prolactin secretion after successful removal of prolactinomas.
    Camanni F; Ghigo E; Ciccarelli E; Massara F; Campagnoli C; Molinatti G; Müller EE
    J Clin Endocrinol Metab; 1983 Dec; 57(6):1270-6. PubMed ID: 6415087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prolactin secretion after surgery or bromocriptine treatment of prolactinoma.
    De Leo V; Petraglia F; Sardelli S; Danero S; Genazzani AR; D'Antona N
    Obstet Gynecol; 1987 Jan; 69(1):99-103. PubMed ID: 3099236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolactin and thyrotropin response to blockade of dopamine synthesis by monoiodotyrosine in subjects with postpartum and pathological hyperprolactinemia.
    Ghigo E; Ciccarelli E; Novelli A; Massobrio M; Müller EE; Camanni F
    J Endocrinol Invest; 1985 Feb; 8(1):35-40. PubMed ID: 3989236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum prolactin response to thyrotropin-releasing hormone and metoclopramide in patients with prolactin-secreting tumors before and after transsphenoidal surgery.
    Barbarino A; De Marinis L; Maira G; Menini E; Anile C
    J Clin Endocrinol Metab; 1978 Nov; 47(5):1148-51. PubMed ID: 122421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamics of prolactin secretion in patients with hypopituitarism and pituitary macroadenomas.
    Arafah BM; Nekl KE; Gold RS; Selman WR
    J Clin Endocrinol Metab; 1995 Dec; 80(12):3507-12. PubMed ID: 8530591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term follow-up of 'cured' prolactinoma patients after successful adenomectomy.
    Ciccarelli E; Ghigo E; Miola C; Gandini G; Muller EE; Camanni F
    Clin Endocrinol (Oxf); 1990 May; 32(5):583-92. PubMed ID: 2114241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence of abnormal dopaminergic control of prolactin in patients with hypothalamic and pituitary tumors.
    Cabranes JA; Almoguera I; del Olmo J; Prensa A; Pablos I; Charro AL
    J Med; 1986; 17(1):25-39. PubMed ID: 3035040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolactin secretion in acromegalic patients before and after selective adenomectomy.
    Tsuchiya H; Onishi T; Takamoto S; Imanaka S; Saitoh Y; Mogami H; Mori S; Uozumi T; Kumahara Y
    J Clin Endocrinol Metab; 1985 Jul; 61(1):104-9. PubMed ID: 3923026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exaggerated circadian variation in basal thyrotropin (TSH) and in the dopaminergic inhibition of TSH release in pathological hyperprolactinemia: evidence against a hypothalamic dopaminergic defect.
    Rodriguez-Arnao MD; Peters JR; Foord SM; Dieguez C; Edwards C; Gomez-Pan A; Hall R; Newcombe RG; Scanlon MF
    J Clin Endocrinol Metab; 1983 Nov; 57(5):975-80. PubMed ID: 6619271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The preoperative and postoperative investigation of TSH and prolactin release in the management of patients with hyperprolactinaemia due to prolactinomas and nonfunctional pituitary tumours: relationship to adenoma size at surgery.
    Scanlon MF; Peters JR; Salvador J; Richards SH; John R; Howell S; Williams ED; Thomas JP; Hall R
    Clin Endocrinol (Oxf); 1986 Apr; 24(4):435-46. PubMed ID: 3091297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is idiopathic hyperprolactinemia a transitional stage toward prolactinoma?
    Pereira MC; Sobrinho LG; Afonso AM; Ferreira JM; Santos MA; Sousa MF
    Obstet Gynecol; 1987 Sep; 70(3 Pt 1):305-8. PubMed ID: 3114691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison between pituitary computed tomographic findings and tests of hypothalamo-pituitary function in 72 patients with hyperprolactinaemia.
    Ghigo E; Ciccarelli E; Bianchi SD; Gatti G; Molinatti GM; Massara F; Müller EE; Camanni F
    Acta Endocrinol (Copenh); 1986 May; 112(1):20-7. PubMed ID: 3087130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persistent defect in regulation of prolactin secretion after successful pituitary tumor removal in women with the galactorrhea-amenorrhea syndrome.
    Tucker HS; Lankford HV; Gardner DF; Blackard WG
    J Clin Endocrinol Metab; 1980 Nov; 51(5):968-71. PubMed ID: 6775003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship of changes in serum estradiol and progesterone during the menstrual cycle to the thyrotropin and prolactin responses to thyrotropin-releasing hormone.
    Sawin CT; Hershman JM; Boyd AE; Longcope C; Bacharach P
    J Clin Endocrinol Metab; 1978 Dec; 47(6):1296-302. PubMed ID: 122427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolactin dynamics and tumour size in the prediction of surgical outcome for prolactinoma.
    Gordon D; Richards A; Bulloch R; Cohen HN; Semple CG; Beastall GH; Thomson JA; Teasdale G
    Q J Med; 1985 Feb; 54(214):141-51. PubMed ID: 3920723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of nomifensine on thyroid-stimulating hormone (TSH) in normal and hyperprolactinemic subjects.
    Giusti M; Mazzocchi G; Mignone D; Tarditi W; Contessini M; Bessarione D; Giordano G
    Neuroendocrinology; 1983 Dec; 37(6):406-10. PubMed ID: 6657002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of extracerebral dopamine on salsolinol- or thyrotropin-releasing hormone-induced prolactin (PRL) secretion in goats.
    Inaba Y; Kato Y; Itou A; Chiba A; Sawai K; Fülöp F; Nagy GM; Hashizume T
    Anim Sci J; 2016 Dec; 87(12):1522-1527. PubMed ID: 26997651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Various aspects of dopaminergic function in patients with prolactin-secreting hypophyseal adenoma].
    De Leo V; Franchi F; Danero S; Ricci MG; La Marca S; Urbani TM; Pieroni ML; D'Antona N; Genazzani AR
    Boll Soc Ital Biol Sper; 1983 Dec; 59(12):1883-9. PubMed ID: 6671047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long term follow-up of women with surgically treated prolactin-secreting pituitary tumors.
    Schlechte JA; Sherman BM; Chapler FK; VanGilder J
    J Clin Endocrinol Metab; 1986 Jun; 62(6):1296-301. PubMed ID: 3084539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered dopaminergic regulation of thyrotrophin release in patients with prolactinomas: comparison with other tests of hypothalamic-pituitary function.
    Scanlon MF; Rodriguez-Arnao MD; McGregor AM; Weightman D; Lewis M; Cook DB; Gomez-Pan A; Hall R
    Clin Endocrinol (Oxf); 1981 Feb; 14(2):133-43. PubMed ID: 6790201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.